Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Certain genetic changes in the KAP22-1 gene are linked to better wool quality in Egyptian sheep.

Eyebrow microblading has aesthetic benefits but needs better public education and stricter regulations due to safety concerns.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Ultrasound biomicroscopy is useful for viewing hair follicles in alopecia areata.

The CAP1 gene helps control ammonium levels and is necessary for the proper growth of root hairs in Arabidopsis.

AB+ blood group is more common in alopecia areata patients.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

More severe hair loss worsens quality of life in men.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

PRP is an effective and safe treatment for hair loss in women.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

ATX-101 injections can cause hair loss.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.